Amplifiers for Restoration of the Bruker 9.4 Tesla Magnetic Resonance Imaging (MRI) Scanner
Overview
Buyer
Place of Performance
NAICS
PSC
Set Aside
Original Source
Timeline
Qualification Details
Fit reasons
- NAICS alignment with historical contract wins in similar service areas.
- Scope strongly matches core technical capabilities and delivery model.
Risks
- Past performance thresholds may require one additional teaming partner.
- Potential clarification needed on staffing minimums before bid/no-bid.
Next steps
Validate eligibility requirements, assign capture owner, and schedule partner outreach to confirm teaming strategy before submission planning.
Quick Summary
The National Institute on Drug Abuse (NIDA) intends to award a non-competitive contract to Bruker BioSpin Corporation for gradient amplifiers and restoration services for its 9.4 Tesla MRI scanner. This is a pre-solicitation notice of intent, not a request for competitive proposals. The purpose is to restore the scanner, a critical tool for addiction research, to operational status. Responses from interested parties are due by February 16, 2026.
Scope of Work
The requirement is to provide a newer version of a gradient amplifier compatible with NIDA's existing Bruker 9.4 Tesla MRI system, which was acquired in 2004 and whose original amplifier has failed. Bruker BioSpin Corporation will also perform necessary hardware and software upgrades to fully reinstate scanner functionality. Qualified Bruker BioSpin Corporation field engineers are required to complete the repair within 30 days of contract award, providing documentation of the restoration. Only an authorized service provider for the Bruker BioSpin Tesla 9.4 MRI Scanner equipment can complete this service.
Contract & Timeline
- Type: Pre-solicitation, Non-Competitive (Notice of Intent) Synopsis
- Intended Awardee: Bruker BioSpin Corporation
- Regulatory Authority: FAR Part 13 – Simplified Acquisition Procedures (Single Source)
- NAICS: 811210 (Size Standard: $34 Million)
- Set-Aside: Not set aside for small businesses
- Intended Award Date: On or around February 27, 2026
- Response Due: February 16, 2026, 6:00 PM UTC
- Published: February 6, 2026
Justification for Sole Source
Market research conducted by NIDA, including contacts with industry/government experts and reviews of product literature, determined that Bruker BioSpin Corporation is the only vendor capable of providing the required services. The original gradient amplifier model is no longer supported, and Bruker is the sole source for compatible upgrades and authorized service for their proprietary system.
Response Information
This is not a request for competitive proposals, but interested parties may submit a capability statement, proposal, or quotation to be considered. Responses should establish bona-fide capabilities and include unit price, list price, shipping, delivery period, prompt payment terms, F.O.B. point, Unique Entity Identifier (UEI), Taxpayer Identification Number (TIN), and business size certification. Offerors must have an active SAM registration. Responses must be submitted electronically to Shaun Rostad (Shaun.rostad@nih.gov) by the deadline, referencing solicitation number 75N95026Q00006.